DuPont (NYSE: DD) announced Friday that its Pioneer Hi-Bred seed business will delay the release of its corn hybrids and soybean varieties products, causing the company’s stock to drop, according to Associated Press.
DuPont said the current version of the trait in corn does not meet Pioneer's high yield standards. As a result, Pioneer has reset its plans to commercialize its Optimum GAT corn and will not have controlled releases in 2010 and 2011 in North America.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The chemicals company also affirmed its agriculture and nutrition business segment's estimated growth rate, but investors pushed Dupont's stock down $2.33, or 6.7 percent, to $32.50 in afternoon trading.
Pioneer plans to intensify its research efforts for the corn trait and work toward commercialization in the middle of the next decade, Dupont said.
Meanwhile, the Wilmington, Del., company said it expects to release its Optimum GAT soybeans two to three years later than the anticipated 2011 introduction due to changes in regulatory policy in key import markets and increasing complexity in managing grain stewardship.
The company said it is "aggressively pursuing" the regulatory approvals, and has already received clearance in the U.S. and Canada.
DuPont affirmed a 15 percent compounded annual earnings growth rate through 2013 at its agriculture and nutrition business segment, one of six company segments.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
